Guideline Recommendations – Diagnosis and Management of Adults with IBS-C

Learner Site

<< Back

0 Item(s)

On Demand

Keyword(s) IBS, guidelines, IBS-C, irritable bowel syndrome, constipation

On-demand course

Credit CME:1.5

Tag(s) CME Only, On Demand, Colon, IBS, Diarrhea and constipation

Description

Modules created to improve knowledge and competencies for assessment and treatment, especially with new therapies for IBS-C, and how to optimally use these guidelines in clinical practice.

Faculty:

Lin Chang, MD, AGAF
Vice-Chief, Vatche and Tamar Manoukian Division of Digestive Diseases
Program Director, UCLA GI Fellowship Program
Co-Director, G. Oppenheimer Center for Neurobiology of Stress and Resilience
David Geffen School of Medicine at UCLA

Anthony Lembo, MD, AGAF
Professor of Medicine
Harvard Medical School
Director, GI Motility Laboratory
Division of Gastroenterology
Beth Israel Deaconess Medical Center

Learning Objectives:

Understand best practices for assessment of IBS-C, and review the current diagnostic criteria for IBS-C
Understand best practices in the management and treatment of patients with IBS-C
Tips for implementation of the new recommendations for IBS-C from AGA’s 2022 guideline, for providers, institutions and patients

Disclosures

Dr. Lin Chang
Ardelyx, Consulting Fee, Advisory Committee/Review Panel: Arena, Consulting Fee, Advisory Committee/Review Panel: Arena, Salary, Grant/Research Support: Bausche Health, Consulting Fee, Consulting: Ironwood, Salary, Grant/Research Support: Ironwood, Consulting Fee, Speaking/Teaching: AbbVie, Consulting Fee, Speaking/Teaching: Immunic, Consulting Fee, Advisory Committee/Review Panel: Mauna Kea Technologies, Consulting Fee, Advisory Committee/Review Panel: Trellus Health, Consulting Fee, Consulting: Trellus Health, Ownership Interest (stocks), Stock Shareholder: ModifyHealth, Ownership Interest (stocks), Stock Shareholder: Rome Foundation, Royalty, Board Member: AnX Robotica, Salary, Grant/Research Support: Vanda, Salary, Grant/Research Support

Dr. Anthony Lembo
Aeon, Consulting Fee, Consulting: Ardylex, Consulting Fee, Consulting: Gemelli, Consulting Fee, Board Member: Gimotti, Consulting Fee, Advisory Committee/Review Panel: Ironwood, Consulting Fee, Advisory Committee/Review Panel: Takeda, Consulting Fee, Advisory Committee/Review Panel: Vibrant, Consulting Fee, Consulting: BioAmerica, Consulting Fee, Consulting: Arena, Consulting Fee, Advisory Committee/Review Panel: cara care, Ownership Interest (stocks), Stock Shareholder: Johnson and Johnson, Ownership Interest (stocks), Stock Shareholder: Bristol Myer Squibb, Ownership Interest (stocks), Stock Shareholder

Accreditation Statement
The AGA Institute is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The AGA Institute designates this other: blended activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

In accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education, all faculty and planning partners must disclose all their financial relationships with ineligible companies held within the past 24 months. The AGA Institute implements a mechanism to identify and mitigate all conflicts of interest prior to delivering the educational activity to learners.

MOC/CME expiration date: May 31, 2024

Sponsors:

The distribution of this educational resource is supported by AbbVie. It is intended for reference use only and healthcare providers must make clinical judgments based on their independent assessment of each patient. AbbVie was not involved in the development of the publication or the underlying guidelines on which this publication is based.